(The TQCC of Hepatology is 75. The table below lists those papers that are above that threshold based on CrossRef citation counts. The publications cover those that have been published in the past four years, i.e., from 2019-03-01 to 2023-03-01.)
A model to predict survival in patients with end-stage liver disease3469
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C2757
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome1907
Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival1596
Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference1483
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis997
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis825
NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome807
Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values787
Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity779
Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States775
Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis723
Chronic hepatitis B642
A proposed system for the nomenclature of hepatitis C viral genotypes621
The management of ascites in cirrhosis: Report on the consensus conference of the International Ascites Club602
Sampling variability of liver fibrosis in chronic hepatitis C600
Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C596
Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators584
Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma583
Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis526
Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: A 16-year prospective study513
Toll-Like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells492
Gene expression of tumor necrosis factor [alpha ] and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients486
Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy485
A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C480
Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C446
Estimating progression to cirrhosis in chronic hepatitis C virus infection440
Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes425
Hepatitis C virus kinetics during and immediately after liver transplantation423
Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis395
Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: Clinically significant or purely “occult”?394
Hepatitis B e antigen–negative chronic hepatitis B384
Cytokines and NASH: A pilot study of the effects of lifestyle modification and vitamin E375
Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps369
Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression365
Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice364
Central role of PPARα-dependent hepatic lipid turnover in dietary steatohepatitis in mice362
High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: A potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis360
Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infe355
Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis350
A multicenter United States—Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B345
Metallothionein‐1G facilitates sorafenib resistance through inhibition of ferroptosis344
A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices332
Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus321
Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis319
Long-Term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C314
Factors affecting liver fibrosis in human immunodeficiency virus–and hepatitis C virus–coinfected patients: Impact of protease inhibitor therapy311
Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan310
A practice guideline on Wilson disease309
Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone308
Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region307
Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease302
Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection301
Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy301
Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: Apoptosis or necrosis?299
The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR299
Heterogeneity and plasticity of hepatocyte lineage cells296
CXCR4 inhibition in tumor microenvironment facilitates anti‐programmed death receptor‐1 immunotherapy in sorafenib‐treated hepatocellular carcinoma in mice293
Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats290
A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C289
Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases289
Hepatitis C virus infection and incident type 2 diabetes288
Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients286
Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013‐2016286
Diagnosis and Treatment of Alcohol‐Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases283
Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States281
Differential CD4+ and CD8+ T-cell responsiveness in hepatitis C virus infection280
Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases276
Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane270
High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C268
Efficacy and safety of pegylated (40-kd) interferon α-2a compared with interferon α-2a in noncirrhotic patients with chronic hepatitis C268
Transforming growth factor β and the liver266
Advances in bioartificial liver devices265
Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy264
Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition258
Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice255
Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization255
The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: A long-term retrospective cohort study251
Genetic polymorphisms and the progression of liver fibrosis: A critical appraisal250
Resection of hepatocellular cancer ≤2 cm: Results from two Western centers248
Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium242
Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta‐Analysis240
Epidemiology of primary hepatic malignancies in U.S. children234
Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats230
Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver230
Renal failure after upper gastrointestinal bleeding in cirrhosis: Incidence, clinical course, predictive factors, and short-term prognosis230
Cellular localization and up-regulation of multidrug resistance–associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver230
Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study228
HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis224
Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals223
Prediction of treatment outcome in patients with chronic hepatitis C: Significance of baseline parameters and viral dynamics during therapy220
Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma217
Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients217
Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis216
A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding216
HNF4: A central regulator of hepatocyte differentiation and function215
Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: Analysis and review of the literature214
Antiangiogenic treatment with Sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats214
Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: A comparative study using a matched,210
Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective208
Intraductal papillary neoplasia of the liver associated with hepatolithiasis207
The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids207
Cholangiocarcinoma: Current concepts and insights206
Changes in WNT/β-catenin pathway during regulated growth in rat liver regeneration206
Diagnosis and management of hemochromatosis205
Transplantation for primary biliary cirrhosis: Retrospective analysis of 400 patients in a single center204
MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease)202
Comparison of two clinical scales for causality assessment in hepatotoxicity201
Effect of ribavirin on hepatitis C viral kinetics in patients treated with pegylated interferon200
Positron emission tomography with [18F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer200
Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C–dependent mechanisms in cholestatic rat 199
Inhibition of hepatitis B virus expression and replication by RNA interference198
Expression and role of Bcl-xL in human hepatocellular carcinomas198
Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: Evidence for Akt inhibition in celecoxib-induced apoptosis197
c-Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration196
The role of Smad3 in mediating mouse hepatic stellate cell activation196
Primary sclerosing cholangitis in children: A long-term follow-up study195
Treatment of hepatitis C infection in injection drug users195
HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis194
Expression of mRNA for DNA methyltransferases and methyl-CpG–binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis194
Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9192
Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems190
Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin188
The normal liver harbors the vitamin D nuclear receptor in nonparenchymal and biliary epithelial cells187
Mother-to-infant transmission of hepatitis C virus185
Mouse A6–positive hepatic oval cells also express several hematopoietic stem cell markers184
Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection?184
Human leukocyte antigen (HLA)-B*57:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury184
Kinetics of the immune response during HBV and HCV infection183
Hepatitis C virus infection in a community in the Nile Delta: Risk factors for seropositivity181
Disrupted signaling and inhibited regeneration in obese mice with fatty livers: Implications for nonalcoholic fatty liver disease pathophysiology181
Complementary and alternative medicine in chronic liver disease180
Drug-induced liver injury: Mechanisms and test systems180
Analysis of hepatitis B viral load decline under potent therapy: Complex decay profiles observed180
Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational Significances180
Risk factors for primary biliary cirrhosis in a cohort of patients from the United States178
A model to predict severe HCV-related disease following liver transplantation177
Role of hepatitis B, C, and D viruses in dual and triple infection: Influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference177
Differentiation of embryonic stem cells into hepatocytes: Biological functions and therapeutic application173
Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection173
A modified choline-deficient, ethionine-supplemented diet protocol effectively induces oval cells in mouse liver172
Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population‐based study172
Detection of functionally altered hepatitis C virus-specific CD4+ T cells in acute and chronic hepatitis C171
Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases171
Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors170
Angiogenesis in chronic inflammatory liver disease170
Durability of serologic response after lamivudine treatment of chronic hepatitis B168
Determinants for sustained HBeAg response to lamivudine therapy167
Long-term follow-up of interferon alfa treatment in chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related com167
Long-Term suppression of hepatitis B e antigen-negative chronic hepatitis B by 24-month interferon therapy166
Treatment strategy for small hepatocellular carcinoma: Comparison of long-term results after percutaneous ethanol injection therapy and surgical resection166
Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non–iron-related chronic liver disease166
Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites165
Prevalence of HBV precore/core promoter variants in the United States163
ADAM12 in human liver cancers: TGF-β-regulated expression in stellate cells is associated with matrix remodeling162
The role of liver biopsy in chronic hepatitis C161
Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection161
Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis159
Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: A study using adenovirus-mediated antisense targeting158
Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS158
Immune checkpoint blockade in hepatocellular carcinoma: Current progress and future directions157
Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic Steatohepatitis157
Circular RNA MAT2B Promotes Glycolysis and Malignancy of Hepatocellular Carcinoma Through the miR‐338‐3p/PKM2 Axis Under Hypoxic Stress155
Cyclins and cyclin-dependent kinases: Comparative study of hepatocellular carcinoma versus cirrhosis154
Familial intrahepatic cholestasis 1: Studies of localization and function154
Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens154
Dual Programmed Death Receptor‐1 and Vascular Endothelial Growth Factor Receptor‐2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma154
Portal cavernoma-associated cholangiopathy: A clinical and MR cholangiography coupled with MR portography imaging study153
Human CD96 Correlates to Natural Killer Cell Exhaustion and Predicts the Prognosis of Human Hepatocellular Carcinoma152
Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers151
Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials151
Viral dynamics and response differences in HCV-infected African American and white patients treated with IFN and ribavirin150
Autoimmune hepatitis with incidental histologic features of bile duct injury150
Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites150
17‐Beta Hydroxysteroid Dehydrogenase 13 Is a Hepatic Retinol Dehydrogenase Associated With Histological Features of Nonalcoholic Fatty Liver Disease150
Establishment, characterization, and long-term maintenance of cultures of human fetal hepatocytes149
Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco149
The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials149
Viral and clinical factors associated with the fulminant course of hepatitis A infection148
Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas148
Human bile contains MicroRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis147
Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis146
Acute hepatitis C145
Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen–negative Chinese carriers145
Long‐Term Risk of Hepatocellular Carcinoma in HCV Patients Treated With Direct Acting Antiviral Agents145
NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis145
Interleukin 6 is important for survival after partial hepatectomy in mice143
Pseudocapillarization and associated energy limitation in the aged rat liver142
Adenosine monophosphate[ndash ]activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia-reperfusion injury in the rat141
Predicting the prognosis of chronic liver disease: An evolution from child to MELD140
RNA expression in the early characterization of hepatotoxicants in Wistar rats by high-density DNA microarrays140
Long noncoding RNA TSLNC8 is a tumor suppressor that inactivates the interleukin‐6/STAT3 signaling pathway140
Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults139
Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor–induced P-selectin up-regulation in the rat139
Differential regulation of TGF-β signal in hepatic stellate cells between acute and chronic rat liver injury138
Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection137
The biliary epithelium gives rise to liver progenitor cells137
Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis136
Long-term histologic and virologic outcomes of acute self-limited hepatitis B136
Angiopoietins and Tie-2 expression in angiogenesis and proliferation of human hepatocellular carcinoma136
The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis136
Mechanisms of benzarone and benzbromarone-induced hepatic toxicity135
Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays134
Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo‐Controlled Trial134
Sex is a major determinant of CYP3A4 expression in human liver132
Sickle cell hepatopathy131
Etoposide prevents apoptosis in mouse liver with ?-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality130
Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances129
Inhibition of microsomal triglyceride transfer protein: Another mechanism for drug-induced steatosis in mice128
Malaria sporozoites actively enter and pass through rat Kupffer cells prior to hepatocyte invasion128
ADAPT: An Algorithm Incorporating PRO‐C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis128
Cigarette smoking and hepatic lesions in patients with chronic hepatitis C127
Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection127
Impact of Sustained Virologic Response with Direct‐Acting Antiviral Treatment on Mortality in Patients with Advanced Liver Disease127
Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis126
Conditional tetracycline-regulated expression of TGF-β1 in liver of transgenic mice leads to reversible intermediary fibrosis124
Antibiotic prophylaxis in cirrhosis: Good and bad124
HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease124
Candidate biomarkers for the diagnosis and prognosis of drug‐induced liver injury: An international collaborative effort124
Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: A double-blind RCT123
Gas exchange mechanism of orthodeoxia in hepatopulmonary syndrome123
Salivary gland progenitor cells induced by duct ligation differentiate into hepatic and pancreatic lineages122
Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis122
Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12122
Interleukin 6/gp130-dependent pathways are protective during chronic liver diseases121
Involvement of p21WAF1/Cip1, p27Kip1, and p18INK4c in troglitazone-induced cell-cycle arrest in human hepatoma cell lines121
Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection121
Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts121
A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation121
Spatiotemporal expression of angiogenesis growth factor receptors during the revascularization of regenerating rat liver120
Mitochondrial oxidative injury and energy metabolism alteration in rat fatty liver: Effect of the nutritional status120
Prospective study on anti-hepatitis C virus–positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA120
Hepatitis C, cryoglobulinemia, and cirrhosis: A meta-analysis119
Sinusoidal ultrastructure evaluated during the revascularization of regenerating rat liver119
Redefining Cirrhotic Cardiomyopathy for the Modern Era119
Hepatic copper metabolism: Insights from genetic disease118
Pharmacokinetics and pharmacodynamic action of budesonide in early- and late-stage primary biliary cirrhosis118
EBP50, a β-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma118
Week 48 resistance surveillance in two phase 3 clinical studies of adefovir dipivoxil for chronic hepatitis B118
Causality assessment versus guilt-by-association in drug hepatotoxicity118
The geographical distribution of primary biliary cirrhosis in a well-defined cohort117
Liraglutide, Sitagliptin, and Insulin Glargine Added to Metformin: The Effect on Body Weight and Intrahepatic Lipid in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease117
Coronavirus Disease 2019 Hangover: A Rising Tide of Alcohol Use Disorder and Alcohol‐Associated Liver Disease117
PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome115
Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats115
Outcome of liver transplantation in patients with diabetes mellitus: A case-control study115
CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease114
Mechanisms for sensitization to TNF-induced apoptosis by acute glutathione depletion in murine hepatocytes113
Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone113
Detoxification of reactive oxygen species by a nonpeptidyl mimic of superoxide dismutase cures acetaminophen-induced acute liver failure in the mouse112
Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease112
Hepatitis C virus infection in the general population: A community-based study in West Bengal, India111
SEN virus infection and its relationship to transfusion-associated hepatitis111
Changing Trends in Etiology‐Based and Ethnicity‐Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States111
Blocking Triggering Receptor Expressed on Myeloid Cells‐1‐Positive Tumor‐Associated Macrophages Induced by Hypoxia Reverses Immunosuppression and Anti‐Programmed Cell Death Ligand 1 Resistance in Live111
Occult hepatitis B virus infection: A hidden menace?110
Role of the hepatocyte nuclear factor 4α in control of the pregnane X receptor during fetal liver development110
A sequential study of serum bacterial DNA in patients with advanced cirrhosis and ascites110
Endoplasmic Reticulum Stress Causes Liver Cancer Cells to Release Exosomal miR‐23a‐3p and Up‐regulate Programmed Death Ligand 1 Expression in Macrophages110
Oxidant-induced hepatocyte injury from menadione is regulated by ERK and AP-1 signaling109
Primary lymphoma of the liver: Clinical-pathological features and relationship with HCV infection in French patients109
Sensitivity of the 2-oxoglutarate carrier to alcohol intake contributes to mitochondrial glutathione depletion108
MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes107
The mitochondrial permeability transition contributes to acute ethanol-induced apoptosis in rat hepatocytes107
Validation and refinement of survival models for liver retransplantation106
Massive liver growth in mice induced by systemic interleukin 6 administration106
Antiviral activity of clevudine [?-FMAU, (1-(2-fluoro-5-methyl-β, ?-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Mar106
Serum mitochondrial biomarkers and damage-associated molecular patterns are higher in acetaminophen overdose patients with poor outcome106
Effects of blood volume restitution following a portal hypertensive–related bleeding in anesthetized cirrhotic rats105
Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: Effects on primary bile acids in babies and mothers105
Octreotide in hepatorenal syndrome: A randomized, double-blind, placebo-controlled, crossover study104
The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis104
Serum Hepatitis B Virus RNA: A New Potential Biomarker for Chronic Hepatitis B Virus Infection104
Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice104
A Noncoding Regulatory RNAs Network Driven by Circ‐CDYL Acts Specifically in the Early Stages Hepatocellular Carcinoma104
All liver recipients benefit from the protocol 10-year liver biopsies103
Genetic variation in the interleukin -28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection102
Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis102
Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm102
Intracellular signaling pathways involved in acetaldehyde-induced collagen and fibronectin gene expression in human hepatic stellate cells102
Bile acid feeding increased proliferative activity and apical bile acid transporter expression in both small and large rat cholangiocytes102
Protracted, but not acute, hepatitis A virus infection is strongly associated with HLA-DRB1*1301, a marker for pediatric autoimmune hepatitis102
Induction of catalase, alpha, and microsomal glutathione S-transferase in CYP2E1 overexpressing HepG2 cells and protection against short-term oxidative stress102
A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis C101
Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection100
TAK1/JNK and p38 have opposite effects on rat hepatic stellate cells100
Cholangiocyte‐Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis100
The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat99
Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease99
Incidence and Mortality of Acute‐on‐Chronic Liver Failure Using Two Definitions in Patients with Compensated Cirrhosis99
Caspase inhibition reduces apoptotic death of cryopreserved porcine hepatocytes98
Inhibition of intrahepatic metastasis of human hepatocellular carcinoma by Rho-associated protein kinase inhibitor Y-2763298
Endothelial cell–mediated uptake of a hepatitis B virus: A new concept of liver targeting of hepatotropic microorganisms98
Activation of retinoic X receptor and peroxisome proliferator–activated receptor-γ inhibits nitric oxide and tumor necrosis factor-α production in rat Kupffer cells98
Burden of Illness and Economic Model for Patients With Nonalcoholic Steatohepatitis in the United States98
The relationship of in vivo31P MR spectroscopy to histology in chronic hepatitis C97
Combination of interferon induction therapy and ribavirin in chronic hepatitis C97
Hereditary thrombophilia as a cause of Budd-Chiari syndrome: A study from Western India97
Activation of caspases occurs downstream from radical oxygen species production, Bcl-xL down-regulation, and early cytochrome C release in apoptosis induced by transforming growth factor β in rat feta97
Rapid diagnosis of spontaneous bacterial peritonitis by use of Reagent Strips96
Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection96
A novel long noncoding RNA Lnc‐HC binds hnRNPA2B1 to regulate expressions of Cyp7a1 and Abca1 in hepatocytic cholesterol metabolism96
Long noncoding RNA H19 interacts with polypyrimidine tract‐binding protein 1 to reprogram hepatic lipid homeostasis96
A Positive Feedback Loop Between Cancer Stem‐Like Cells and Tumor‐Associated Neutrophils Controls Hepatocellular Carcinoma Progression96
The kidney plays a major role in the hyperammonemia seen after simulated or actual GI bleeding in patients with cirrhosis95
Propranolol for the prevention of first esophageal variceal hemorrhage: A lifetime commitment?95
Prevalence and risk factors for hepatitis C virus infection at an Urban veterans administration medical center95
The Role of Senescence in the Development of Nonalcoholic Fatty Liver Disease and Progression to Nonalcoholic Steatohepatitis95
Protein kinase C–dependent distribution of the multidrug resistance protein 2 from the canalicular to the basolateral membrane in human HepG2 cells94
Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon‐Free Therapy93
Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic Hepatitis93
Diagnosing fibrosis in hepatitis C: Is the pendulum swinging from biopsy to blood tests?92
Cholestatic expression pattern of sinusoidal and canalicular organic anion transport systems in primary cultured rat hepatocytes92
Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L‐PLUS 2)92
Hepatic osteodystrophy92
PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomas91
Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma91
FUN14 Domain‐Containing 1–Mediated Mitophagy Suppresses Hepatocarcinogenesis by Inhibition of Inflammasome Activation in Mice90
Pharmacological Inhibition of CCR2/5 Signaling Prevents and Reverses Alcohol‐Induced Liver Damage, Steatosis, and Inflammation in Mice90
Normal hepatocytes correct serum bilirubin after repopulation of Gunn rat liver subjected to irradiation/partial resection90
Interferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis C89
Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response89
High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity89
The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis89
Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis89
Dysregulated Autophagy and Lysosome Function Are Linked to Exosome Production by Micro‐RNA 155 in Alcoholic Liver Disease89
Vitamin E Improves Transplant‐Free Survival and Hepatic Decompensation Among Patients With Nonalcoholic Steatohepatitis and Advanced Fibrosis89
Hepatitis C virus and liver disease: Global transcriptional profiling and identification of potential markers88
Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease88
Restoration of cerebral blood flow autoregulation and reactivity to carbon dioxide in acute liver failure by moderate hypothermia87
Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis87
Sorafenib Induces Pyroptosis in Macrophages and Triggers Natural Killer Cell–Mediated Cytotoxicity Against Hepatocellular Carcinoma87
Longitudinal Assessment of Three Serum Biomarkers to Detect Very Early‐Stage Hepatocellular Carcinoma87
Visualization of early events in tumor formation of eGFP-transfected rat colon cancer cells in liver86
Characterization of the mouse bile salt export pump overexpressed in the baculovirus system86
Global changes in interleukin-6–dependent gene expression patterns in mouse livers after partial hepatectomy86
Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: Prediction and impact on long‐term survival86
Microdissection-based allelotyping discriminates de novo tumor from intrahepatic spread in hepatocellular carcinoma85
Nitric oxide-mediated cytoprotection of hepatocytes from glucose deprivation-induced cytotoxicity: Involvement of heme oxygenase-185
The Role of Complement in Liver Injury, Regeneration, and Transplantation85
Moderate alcohol consumption increases oxidative stress in patients with chronic hepatitis C84
Keratin mutation in transgenic mice predisposes to Fas but not TNF-induced apoptosis and massive liver injury84
Ezrin-radixin-moesin–binding phosphoprotein 50 is expressed at the apical membrane of rat liver epithelia84
Notch receptor expression in adult human liver: A possible role in bile duct formation and hepatic neovascularization84
Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure84
Nonalcoholic Steatohepatitis Is Associated With Liver‐Related Outcomes and All‐Cause Mortality in Chronic Hepatitis B84
American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease84
Alcohol-induced liver injury in mice lacking Cu, Zn-superoxide dismutase83
RNA helicase DEAD box protein 5 regulates Polycomb repressive complex 2/Hox transcript antisense intergenic RNA function in hepatitis B virus infection and hepatocarcinogenesis83
Potential role of PTEN phosphatase in ethanol-impaired survival signaling in the liver82
Adjuvant intra-arterial injection of iodine-131–labeled lipiodol after resection of hepatocellular carcinoma82
Antibiotic‐Associated Disruption of Microbiota Composition and Function in Cirrhosis Is Restored by Fecal Transplant82
Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis82
Proteomic analysis and molecular characterization of tissue ferritin light chain in hepatocellular carcinoma82
Autoimmune overlap syndromes81
A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis81
Combination of interferon and ribavirin in chronic hepatitis C: Re-treatment of nonresponders to interferon81
Oxidative stress in fatty livers of obese Zucker rats: Rapid amelioration and improved tolerance to warm ischemia with tocopherol81
Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro81
Impaired IRS-1/PI3-kinase signaling in patients with HCV: A mechanism for increased prevalence of type 2 diabetes80
Hepatitis C virus–like particles induce virus-specific humoral and cellular immune responses in mice80
Induction of Oxidative Stress Through Inhibition of Thioredoxin Reductase 1 Is an Effective Therapeutic Approach for Hepatocellular Carcinoma80
Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver Disease80
Hepatocyte‐Specific β‐Catenin Deletion During Severe Liver Injury Provokes Cholangiocytes to Differentiate Into Hepatocytes79
Molecular identification of bacterial 16S ribosomal RNA gene in liver tissue of primary biliary cirrhosis: Is Propionibacterium acnes involved in granuloma formation?79
Thromboelastography‐Guided Blood Component Use in Patients With Cirrhosis With Nonvariceal Bleeding: A Randomized Controlled Trial79
Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis78
Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line78
Indomethacin prevents the development of experimental ammonia-induced brain edema in rats after portacaval anastomosis78
Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: Effects of transjugular intrahepatic portosystemic shunts78
Sustained expression of naked plasmid DNA encoding hepatocyte growth factor in mice promotes liver and overall body growth78
Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: Impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis78
Alcoholic hepatitis: Translational approaches to develop targeted therapies78
Age and Sex but Not ATP7B Genotype Effectively Influence the Clinical Phenotype of Wilson Disease78
Adult living donor liver transplantation: The hepatologist's perspective77
Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis77
Interferon and ribavirin for patients with chronic hepatitis C who did not respond to previous interferon therapy: A meta-analysis of controlled and uncontrolled trials77
Nonheavy Drinking and Worsening of Noninvasive Fibrosis Markers in Nonalcoholic Fatty Liver Disease: A Cohort Study77
Long Noncoding RNA p53‐Stabilizing and Activating RNA Promotes p53 Signaling by Inhibiting Heterogeneous Nuclear Ribonucleoprotein K deSUMOylation and Suppresses Hepatocellular Carcinoma77
Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression76
Repopulation of rat liver by fetal hepatoblasts and adult hepatocytes transduced ex vivo with lentiviral vectors76
Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: An observational study76
Signal pathway involved in the development of hypoxic preconditioning in rat hepatocytes76
Targeting dexamethasone to Kupffer cells: Effects on liver inflammation and fibrosis in rats76
Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis76
Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection76
Membrane cholesterol but not putative receptors mediates anandamide-induced hepatocyte apoptosis75
Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin75
Outcome of hospital care of liver disease associated with hepatitis C in the United States75
Expression of cyclooxygenase-2 promotes the release of matrix metalloproteinase-2 and -9 in fetal rat hepatocytes75
Earlier expression of the transcription factor HFH-11B diminishes induction of p21CIP1/WAF1 levels and accelerates mouse hepatocyte entry into S-phase following carbon tetrachloride liver injury75
Antiplatelet therapy and the risk of hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment75
Terlipressin Is Superior to Noradrenaline in the Management of Acute Kidney Injury in Acute on Chronic Liver Failure75